GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Cash Flow from Discontinued Operations

Rubius Therapeutics (STU:5RT) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Dec. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Rubius Therapeutics's cash flow from discontinued operations for the three months ended in Dec. 2022 was €0.00 Mil. It means Rubius Therapeutics received €0.00 Mil from the sale of part of business quarterly. Rubius Therapeutics's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00 Mil.

Rubius Therapeutics Cash Flow from Discontinued Operations Historical Data

The historical data trend for Rubius Therapeutics's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubius Therapeutics Cash Flow from Discontinued Operations Chart

Rubius Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial - - - - -

Rubius Therapeutics Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Rubius Therapeutics Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rubius Therapeutics Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Rubius Therapeutics's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Rubius Therapeutics (STU:5RT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
CFRX ADTX NBY NBRVF BXRX INM GLMD HSTO BLCM SPRC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
124 Washington Street, Suite 101, Foxborough, MA, USA, 02035
Website
https://www.rubiustx.com
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Rubius Therapeutics (STU:5RT) Headlines

No Headlines